Importantly, statistical analysis of TNM stages supported a positive relevance between high PAK5 expression and advanced CRC malignancy, pointing out a potential of PAK5 to serve as a prognostic biomarker in CRC in the future. Here, PAK5 is linked to colorectal carcinoma.